RegWardenFDA facility compliance records
Facility

ENDOTRONIX (Naperville)

1 recall(s) on record — most severe on record: Class II.

Activity by year

FDA actions on record by year2019: 1 recalls; 2024: 2 inspections201720181201920202021202220232202420252026
  • Recalls (1)
  • Inspections (2)

Devices registered here (1)

Recalls & enforcement

  • Class IITerminated2019-09-25
    The firm have received reports of patients myCordella Hubs fully powering themselves down without interaction from the patient or Endotronix.

FDA inspections (2)

  • NAI2024-06-11
    No Action Indicated · Bioresearch Monitoring
  • NAI2024-02-27
    No Action Indicated · Compliance: Devices; Postmarket Assurance: Devices

Source: U.S. FDA Inspections Dashboard (opens in a new tab) (device inspection classifications, 2016–present). Data as of 2026-10-06. The dashboard profile can take several seconds to load.

Related

Source: U.S. FDA via openFDA (opens in a new tab) (device registration & enforcement). Data as of 2026-10-06. Verify this facility record at FDA → (opens in a new tab)

Cite this record

RegWarden. “ENDOTRONIX (Naperville) (FEI 3024985933) — FDA facility record.” Compiled from U.S. FDA public records (openFDA; FDA Data Dashboard). Data as of 2026-10-06. https://regwarden.com/facility/3024985933-endotronix-naperville/

Not open yet

Alerts for ENDOTRONIX (Naperville)

Watchlist alerts will email you when FDA publishes a new recall, inspection classification, or warning letter for a facility you follow. They aren't open to the public yet — leave your email and we'll tell you when they are.

Planned

Want a one-page facility brief?

A single-page summary of this facility's registration and recall history for diligence. Not selling it yet — register interest and we'll follow up.